-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Early Management of Acute Promyelocytic Leukemia (APML) (ticketed session for in-person participants)

Program: How I Treat: Bringing Science to Clinical Dilemmas
Hematology Disease Topics & Pathways:
Diseases, Myeloid Malignancies
Sunday, December 10, 2023: 8:00 AM-9:00 AM
Aqua Salon F (Hilton San Diego Bayfront)
Speaker:
Martin S. Tallman, MD, Northwestern University Feinberg School of Medicine
Disclosures:
Tallman: AbbVie: Research Funding; Orsenix: Research Funding; BioSight: Research Funding; Glycomimetics: Research Funding; Rafael Pharmaceuticals: Research Funding; Amgen: Research Funding; Innate Pharmaceuticals: Consultancy; Ipsen Biopharmaceuticalas: Consultancy; Kura: Consultancy; Novartis: Consultancy; American Society of Hematology: Honoraria, Membership on an entity's Board of Directors or advisory committees; HOVON: Membership on an entity's Board of Directors or advisory committees; Foghorn: Membership on an entity's Board of Directors or advisory committees; UpToDate: Patents & Royalties.